2019
DOI: 10.1016/j.jor.2019.05.001
|View full text |Cite
|
Sign up to set email alerts
|

Role of SREBP2 gene polymorphism on knee osteoarthritis in the South Indian Hyderabad Population: A hospital based study with G595C variant

Abstract: Introduction: Osteoarthritis (OA) is a multifactorial disease with genetic factors playing a crucial role, and it has been associated with a family history of obesity. G595C polymorphism in the sterol regulatory element-binding protein 2 (SREBP2) gene has demonstrated an association with knee osteoarthritis (KOA) patients. However, this polymorphism has been never explored in an Indian population. Hence, the current study aimed to examine whether G595C (rs2228314) polymorphism in SREBP2 gene was associated wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 53 publications
0
5
0
Order By: Relevance
“…Knee osteoarthritis (OA) is common [ 6 , 94 ]. Knee OA impairs joint function and quality of life, limiting physical activities and patient independency [ 71 , 73 , 115 ].…”
Section: Introductionmentioning
confidence: 99%
“…Knee osteoarthritis (OA) is common [ 6 , 94 ]. Knee OA impairs joint function and quality of life, limiting physical activities and patient independency [ 71 , 73 , 115 ].…”
Section: Introductionmentioning
confidence: 99%
“…A value of p < 0.05 was considered significant for all statistical purposes. All the analysis was performed by using IBM-SPSS 25 (Armonk, NY; USA) ( Poornima et al, 2019 ).…”
Section: Methodsmentioning
confidence: 99%
“…The expression of the LDLR is regulated at the transcriptional level by the sterol regulatory element-binding protein 2 (SREBP-2), and at the post-translational level primarily by proprotein convertase subtilisin/kexin-type 9 (PCSK9), a regulator that prompts the degradation of the LDLR [2,3]. Specifically, SREBP-2, a member of the nuclear transcription factor family, binds to the sterol regulator in lipid synthetic enzyme gene promoters, activating transcription and gene transcription in the cholesterol biosynthesis pathway [3]. The SREBP-2 gene has been implicated in various metabolic disorders, including obesity and metabolic syndrome [3].…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, SREBP-2, a member of the nuclear transcription factor family, binds to the sterol regulator in lipid synthetic enzyme gene promoters, activating transcription and gene transcription in the cholesterol biosynthesis pathway [3]. The SREBP-2 gene has been implicated in various metabolic disorders, including obesity and metabolic syndrome [3]. Circulating PCSK9 attaches to the LDLR, resulting in lysosomal degradation within the cells [4].…”
Section: Introductionmentioning
confidence: 99%